Description

1H-Pyrazole-1-Acetic Acid, 4-[5,6-Dihydro-2-[3-Methyl-1-(1-Methylethyl)-1H-1,2,4-Triazol-5-Yl]Imidazo[1,2-D][1,4]Benzoxazepin-9-Yl]-α,α-Dimethyl- is a high-purity, complex heterocyclic compound serving as a critical advanced pharmaceutical intermediate in modern drug discovery and development. Its intricate molecular architecture makes it a valuable building block for synthesizing novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring high specificity. This product is essential for research institutions and pharmaceutical manufacturers engaged in the development of new chemical entities.

Application

• Pharmaceutical Intermediate: Key synthetic precursor in the research and production of novel drug candidates, especially in oncology and central nervous system (CNS) therapeutic areas.
• Medicinal Chemistry Research: Used as a sophisticated scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Biochemical Research: Serves as a tool compound or a ligand in probing biological pathways and enzyme interactions due to its complex heterocyclic structure.
• Custom Synthesis: A starting material for the contract synthesis of specialized, high-value target molecules for clinical trials and niche applications.
• Agrochemical Intermediate: Potential use in the development of next-generation pesticides and herbicides, leveraging its bioactive heterocyclic core.

Basic Information

Product Name	1H-Pyrazole-1-Acetic Acid, 4-[5,6-Dihydro-2-[3-Methyl-1-(1-Methylethyl)-1H-1,2,4-Triazol-5-Yl]Imidazo[1,2-D][1,4]Benzoxazepin-9-Yl]-α,α-Dimethyl-
CAS No.	1282513-03-4
Molecular Formula	C26H30N8O3
Molecular Weight	502.57 g/mol
Synonyms	4-[5,6-Dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9-yl]-α,α-dimethyl-1H-pyrazole-1-acetic acid; 1H-Pyrazole-1-acetic acid, 4-[5,6-dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9-yl]-α,α-dimethyl-; UNII-8S4N1Q2W2P; 8S4N1Q2W2P; CAS 1282513-03-4
EINECS	Contact for details

Quality Control

Our 1H-Pyrazole-1-Acetic Acid derivative is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical R&D. Certificates of Analysis (COA) detailing batch-specific results are available upon request, providing full traceability and compliance documentation for your quality assurance protocols.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). This compound may be hygroscopic (moisture-sensitive); therefore, the container should be kept tightly sealed in a dry environment. For long-term storage, consider conditions under an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.